For at modvirke bivirkninger som palmar- plantart erythrodysæstesi (PPE), stomatitis eller hæmatologisk toksicitet, kan dosis reduceres eller udskydes.
To manage adverse events such as palmar-plantar erythrodysesthesia (PPE), stomatitis or haematological toxicity, the dose may be reduced or delayed.